www.fdanews.com/articles/101025-pluristem-completes-construction-of-its-gmp-facilities
Pluristem Completes Construction of Its GMP Facilities
November 13, 2007
Pluristem Life Systems, a leading bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of malignant, Ischemic and auto-immune disorders, announced that it has completed the construction of its new state-of-the-art GMP (good manufacturing practice) facilities.
Business Wire